Determining the Need for Standardized Infusions and Concentrations at Hospitals within North Carolina
- PMID: 38745569
- PMCID: PMC11089628
- DOI: 10.1310/hpj5103-237
Determining the Need for Standardized Infusions and Concentrations at Hospitals within North Carolina
Abstract
Background: In 2013, the American Society of Health-System Pharmacists (ASHP) endorsed a policy recommending the development of nationally standardized drug concentrations and dosing units. Although many hospitals have started standardizing their intravenous (IV) solutions, few have taken the practice beyond their institutions or local geographical areas.
Objective: This project evaluates the current IV standardization practices for adult patients across hospitals in North Carolina and compares them with each other. In addition, this project proposed standards and evaluated them for their impact on reducing observed variability.
Methods: In the fall of 2013, an e-mail request was sent to select hospital pharmacy leaders in North Carolina asking them to voluntarily submit a copy of their adult IV standard concentrations and dosing guidelines. From these lists, the data were summarized and compiled to evaluate trends and compare the various policies.
Results: A total of 18 different hospitals and health systems responded. Survey results showed more than 255 concentrations for 84 unique drugs. Of these, 37 were high-risk medications, with 135 unique drug concentrations. From this list, a single proposed concentration was developed for each medication. If utilized, this standardization would result in a greater than 65% reduction in potential drug concentrations in use. A single dosing unit was also proposed for all medications reviewed, resulting in a greater than 21% reduction in variation.
Conclusions: Standardization of IV drug concentrations and dosing units statewide could reduce the variability in IV therapies and promote safer and more consistent practices in medication administration.
Keywords: intravenous drug therapy; medication safety; standardized drug infusions; standardized practice.
© 2016 SAGE Publications.
References
-
- Kohn L.T. Corrigan J.M. Donaldson M.S., eds. Committee on Quality of Health Care in America; Institute of Medicine. To Err is Human: Building a Safer Health System. Washington, DC: National Academies Press; 2003. - PubMed
-
- Nicholas PK and Agius C.R. Toward safer IV medication administration: The narrow safety margins of many IV medications make this route particularly dangerous. Am J Nurs. 2005; 105(suppl 3): 25–30. - PubMed
-
- Bates D.W. Cullen D.J. Laird N. et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA. 1995; 274(1): 29–34. - PubMed
-
- Winterstein A.G. Hatton R.C. Gonzalez-Rothi R. et al. Identifying clinically significant preventable adverse drug events through a hospital's database of adverse drug reaction reports. Am J Health Syst Pharm. 2002; 59(18): 1742–1749. - PubMed
-
- National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP). NCC MERP taxonomy of medication errors. 1998. www.nccmerp.org/pdf/taxo2001-07-31.pdf. Accessed January 21, 2014.
LinkOut - more resources
Full Text Sources